These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells. Wu SJ, Sadigh S, Lane AA, Pinkus GS. Am J Clin Pathol; 2023 May 02; 159(5):455-463. PubMed ID: 36880313 [Abstract] [Full Text] [Related]
5. Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms. Suzuki Y, Kato S, Kohno K, Satou A, Eladl AE, Asano N, Kono M, Kato Y, Taniwaki M, Akiyama M, Nakamura S. Histopathology; 2017 Dec 02; 71(6):972-984. PubMed ID: 28795410 [Abstract] [Full Text] [Related]
6. IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression. Tang H, Panse G, Braddock D, Perincheri S, Xu ML, McNiff JM. J Cutan Pathol; 2023 Jul 02; 50(7):595-600. PubMed ID: 37082914 [Abstract] [Full Text] [Related]
7. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm. Hwang K, Park CJ, Jang S, Chi HS, Huh JR, Lee JH, Suh C, Lee KH. Histopathology; 2013 Apr 02; 62(5):764-70. PubMed ID: 23470050 [Abstract] [Full Text] [Related]
8. Blastic Plasmacytoid Dendritic Cell Neoplasm. Jain A, Sweet K. J Natl Compr Canc Netw; 2023 May 02; 21(5):515-521. PubMed ID: 37156483 [Abstract] [Full Text] [Related]
9. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches. Cheng W, Yu TT, Tang AP, He Young K, Yu L. Curr Med Sci; 2021 Jun 02; 41(3):405-419. PubMed ID: 34218354 [Abstract] [Full Text] [Related]
10. E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm. Lorenzi L, Lonardi S, Vairo D, Bernardelli A, Tomaselli M, Bugatti M, Licini S, Arisi M, Cerroni L, Tucci A, Vermi W, Giliani SC, Facchetti F. Am J Surg Pathol; 2021 Oct 01; 45(10):1428-1438. PubMed ID: 34081040 [Abstract] [Full Text] [Related]
16. Comparison and Development of Immunohistochemical Diagnostic Criteria for Blastic Plasmacytoid Dendritic Cell Neoplasm. Sakamoto K, Baba S, Okumura Y, Momose S, Ono S, Tonooka A, Ichinohasama R, Takakuwa E, Nakasone H, Ohshima K, Takeuchi K. Mod Pathol; 2023 Oct 01; 36(10):100253. PubMed ID: 37380058 [Abstract] [Full Text] [Related]
17. Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm. Xue T, Budde LE. Hematol Oncol Clin North Am; 2020 Jun 01; 34(3):575-587. PubMed ID: 32336421 [Abstract] [Full Text] [Related]
18. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Pemmaraju N, Madanat YF, Rizzieri D, Fazal S, Rampal R, Mannis G, Wang ES, Foran J, Lane AA. Leuk Lymphoma; 2024 May 01; 65(5):548-559. PubMed ID: 38391126 [Abstract] [Full Text] [Related]